The CABOLD study: A real life prospective cohort evaluating the combination of cabozantinib and nivolumab among older patients with renal-cell carcinoma.
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Institutions: Institut Gustave Roussy, Fondation Gustave Roussy
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Ipsen
OpenAlex ID: W4407699541